BRIEF—Pharma event in Japan falls victim to COVID-19 – more to follow?

The CPhI Japan event has become the latest victim of the coronavirus (COVID-19).

Attendees had requested the postponement of the event, which is organised by Informa Markets and was due to take place in Tokyo from March 16 to 18.

Christopher Eve, managing director, Informa Markets and UBM Japan, said: "The event is now in its 18th edition and we have always listened to the feedback of our exhibitors and attendees. Due to unforeseen circumstances of COVID-19, many felt that it will be difficult to travel to the exhibition at this time. We will work with our attendees and exhibitors so that we can deliver another successful event for everyone involved. We wanted to communicate this as fast as possible, and we will confirm the new dates imminently."

March marks the start of the busiest part of the year for pharmaceutical conferences, so the CPhI Japan event is unlikely to be only one that has to be rescheduled due to COVID-19 and the resultant disruption.